Follicle-stimulating hormone promotes RANK expression on human monocytes

Cytokine

Volumn 53, Issue 2, 2011, Pages 141-144

  Cannon, Joseph G ^a   Kraj, Barbara ^a   Sloan, Gloria ^a  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

Flow cytometry; Follicle stimulating hormone; Human; Monocytes; RANK

Indexed keywords

CD14 ANTIGEN; COLONY STIMULATING FACTOR 1; FOLLITROPIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL MATURATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; HORMONE ACTION; HUMAN; HUMAN CELL; MALE; MONOCYTE; OSTEOCLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTIGENS, CD14; FEMALE; FLOW CYTOMETRY; FOLLICLE STIMULATING HORMONE, HUMAN; HUMANS; MACROPHAGE COLONY-STIMULATING FACTOR; MALE; MIDDLE AGED; MONOCYTES; OSTEOPROTEGERIN; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 78651078968     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.11.011     Document Type: Article

References (18)

1. Sowers M.F., Zheng H., McConnell D., Nan B., Harlow S., Randolph J.F. Follicle stimulating hormone and its rate of change in defining menopause transition stages. J Clin Endocrinol Metab 2008, 93:3958-3964.
2. Sowers M.R., Finkelstein J.S., Ettinger B., Bondarenko I., Neer R.M., Cauley J.A., et al. The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN. Osteoporos Int 2003, 14:44-52.
3. Prior J.C. Perimenopause: the complex endocrinology of the menopausal transition. Endocr Rev 1998, 19:397-428.
4. Fujikawa Y., Quinn J.M.W., Sabokbar A., McGee J.O.D., Athanasou N.A. The human osteoclast precursor circulates in the monocyte fraction. Endocrinology 1996, 137:4058-4060.
5. Massey H.M., Flanagan A.M. Human osteoclasts derive from CD14-positive monocytes. Br J Haematol 1999, 106:167-170.
6. Theill L.E., Boyle W.J., Penninger J.M. RANK-L and RANK: T cells, bone loss, and mammalian evolution. Ann Rev Immunol 2002, 20:795-823.
7. Atkins G.J., Kostakis P., Vincent C., Farrugia A.N., Houchins J.P., Findlay D.M., et al. RANK expression as a cell surface marker of human osteoclast precursors in peripheral blood, bone marrow, and giant cell tumors of bone. J Bone Miner Res 2006, 21:1339-1349.
8. Arai F., Miyamoto T., Ohneda O., Inada T., Sudo T., Brasel K., et al. Commitment and differentiation of osteoclast precursor cells by the sequential expression of c-Fms and receptor activator of nuclear factor-κB (RANK) receptors. J Exp Med 1999, 190:1741-1754.
9. Anderson D.M., Maraskovsky E., Billingsley W.L., Dougall W.C., Tometsko M.E., Roux E.R., et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997, 390:175-179.
10. Yun T.J., Chaudhary P.M., Shu G.L., Frazer J.K., Ewings M.K., Schwartz S.M., et al. OPG/FDCR-1, TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40. J Immunol 1998, 161:6113-6121.
11. Iqbal J., Sun L., Kumar T.R., Blair H.C., Zaidi M. Follicle-stimulating hormone stimulates TNF production from immune cells to enhance osteoblast and osteoclast formation. Proc Natl Acad Sci USA 2006, 103:14925-14930.
12. Morgan E., Varro R., Sepulveda H., Ember J.A., Apgar J., Wilson J., et al. Cytometric bead array: a multiplexed platform with applications in various areas of biology. Clin Immunol 2004, 110:252-266.
13. Sun L., Peng Y., Sharrow A.C., Iqbal J., Zhang Z., Papachristou D.J., et al. FSH directly regulates bone mass. Cell 2006, 125:247-260.
14. Sowers M.F., Jannausch M., McConnell D., Little R., Greendale G.A., Finkelstein J.S., et al. Hormone predictors of bone mineral density changes during the menopausal transition. J Clin Endocrinol Metab 2006, 91:1261-1267.
15. Lari R., Kitchener P.D., Hamilton J.A. The proliferative human monocyte subpopulation contains osteoclast precursors. Arthritis Res Ther 2009, 11:R23.
16. Leibbrandt A., Penninger J.M. RANK/RANKL: regulators of immune responses and bone physiology. Ann NY Acad Sci 2008, 1143:123-150.
17. Rogers A., Eastell R. Review: circulating osteoprotegerin and receptor activator for nuclear factor-κB ligand: clinical utility in metabolic bone disease assessment. J Clin Endocrinol Metab 2005, 90:6323-6331.
18. Bergh C. Recombinant follicle stimulating hormone. Hum Reprod 1999, 14:1418-1419.